v3.25.4
Condensed Consolidated Statements of Changes in Shareholders' Equity (Unaudited) - USD ($)
shares in Thousands, $ in Thousands
Total
Common Shares
Accumulated Deficit
Beginning balance at Mar. 31, 2024 $ 27,683 $ 63,733 $ (36,050)
Beginning balance, shares at Mar. 31, 2024   211,381  
Private placements of shares , value 1,239 $ 1,239  
Private placements of shares   31,200  
Shares issued for restricted stock units,value 220 $ 220  
Shares issued for restricted stock units   313  
Shares issued for bonus , value 16 $ 16  
Shares issued for bonus   14  
Share-based compensation 1,095 $ 1,095  
Net income (loss) for the period (3,846)   (3,846)
Ending balance , value at Dec. 31, 2024 26,407 $ 66,303 (39,896)
Ending balance , shares at Dec. 31, 2024   242,908  
Beginning balance at Sep. 30, 2024 36,879 $ 65,866 (28,987)
Beginning balance, shares at Sep. 30, 2024   242,908  
Share-based compensation 437 $ 437  
Net income (loss) for the period (10,909)   (10,909)
Ending balance , value at Dec. 31, 2024 26,407 $ 66,303 (39,896)
Ending balance , shares at Dec. 31, 2024   242,908  
Beginning balance at Mar. 31, 2025 26,590 $ 66,156 (39,566)
Beginning balance, shares at Mar. 31, 2025   268,992  
Private placements of shares , value 1,251 $ 1,251  
Private placements of shares   40,575  
Shares issued for restricted stock units   2,706  
Shares issued for restricted stock awards , value 18 $ 18  
Shares issued for restricted stock awards   4,600  
Shares cancelled , value (75) $ (75)  
Shares cancelled   (300)  
Share-based compensation 523 $ 523  
Share issuance costs (343) (343)  
Net income (loss) for the period 5,420   5,420
Ending balance , value at Dec. 31, 2025 33,384 $ 67,530 (34,146)
Ending balance , shares at Dec. 31, 2025   316,573  
Beginning balance at Sep. 30, 2025 32,156 $ 67,056 (34,900)
Beginning balance, shares at Sep. 30, 2025   296,803  
Private placements of shares , value 219 $ 219  
Private placements of shares   12,464  
Shares issued for restricted stock units   2,706  
Shares issued for restricted stock awards , value 18 $ 18  
Shares issued for restricted stock awards   4,600  
Share-based compensation 386 $ 386  
Share issuance costs (149) (149)  
Net income (loss) for the period 754   754
Ending balance , value at Dec. 31, 2025 $ 33,384 $ 67,530 $ (34,146)
Ending balance , shares at Dec. 31, 2025   316,573